Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
about
Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.Ocular drug delivery system: a reference to natural polymers.Nanoparticles in the ocular drug delivery.Solid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Nanoparticles for drug delivery to the anterior segment of the eye.Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.Ocular delivery of proteins and peptides: challenges and novel formulation approaches.Essential oil-loaded lipid nanoparticles for wound healing.Recent advances in topical nano drug-delivery systems for the anterior ocular segment.Modification of solid lipid nanoparticles loaded with nebivolol hydrochloride for improvement of oral bioavailability in treatment of hypertension: polyethylene glycol versus chitosan oligosaccharide lactate.Trehalose is not a universal solution for solid lipid nanoparticles freeze-dryingChitosan-coated solid lipid nanoparticles enhance the oral absorption of insulinIn vitrolipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic extract
P2860
Q36697414-6567F258-9258-45C7-8159-53B493D6DBD2Q37996097-481818C7-0478-401B-9354-693E4BD8F663Q38019052-BF82B1B2-8CC3-4AA7-910C-89D48B54B8DAQ38119238-58C18C63-F618-441D-8180-EB7DEF65B4C8Q38160303-A60BB9DC-E5CD-4CF6-8F62-18E39A5C41DCQ38648168-C0B10B8B-C594-429E-8F02-0E143C5836EFQ39230212-D6E97A20-1FDD-4851-AC8F-E251D7BDB62BQ47447720-FDC5BD2B-ED11-4530-B3C6-44072BFB695CQ47729137-B666E42C-2DCD-428B-A138-3A24E26912F0Q49988217-F4C88849-FD20-411D-8F1F-56ADA152BC3BQ50082031-26F36E88-BC69-47D5-93F0-1DDA83D341E3Q50927252-8979CB78-D660-4AC7-B962-F544A5C66BACQ57094988-3B1D594B-979E-44E5-9753-146B1B6E23E5Q57570886-00DA152A-BE1E-4475-A9A7-45BA28E4A8E4Q59155894-45998BF0-5311-483A-94F3-AEF2B500EF89
P2860
Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Chitosan-associated SLN: in vi ...... e A loaded ophthalmic systems.
@ast
Chitosan-associated SLN: in vi ...... e A loaded ophthalmic systems.
@en
type
label
Chitosan-associated SLN: in vi ...... e A loaded ophthalmic systems.
@ast
Chitosan-associated SLN: in vi ...... e A loaded ophthalmic systems.
@en
prefLabel
Chitosan-associated SLN: in vi ...... e A loaded ophthalmic systems.
@ast
Chitosan-associated SLN: in vi ...... e A loaded ophthalmic systems.
@en
P2093
P2860
P1476
Chitosan-associated SLN: in vi ...... e A loaded ophthalmic systems.
@en
P2093
Carla Caramella
Evren Homan Gökçe
Franca Ferrari
Maddalena Patrini
Silvia Rossi
P2860
P304
P356
10.3109/02652048.2010.517854
P577
2010-01-01T00:00:00Z